Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
European Urology Oncology|February 7, 2024
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted AnalysisRonald Kool, Alice Dragomir, Girish S Kulkarni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2024
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted AnalysisGautier Marcq, Ronald Kool, Alice Dragomir, et al.European Urology|October 22, 2013
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over timeGuillaume Ploussard, Shahrokh F Shariat, Alice Dragomir, et al.Clinical Genitourinary Cancer|April 27, 2025
Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World StudyGhady Bou-Nehme Sawaya, Simon Tanguay, Lori A Wood, et al.European Urology Focus|November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian CentersAlice Dragomir, Sara Nazha, Simon Tanguay, et al.European Urology Oncology|December 14, 2023
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic TherapiesGhady Bou-Nehme Sawaya, Alice Dragomir, Lori A Wood, et al.BJU International|December 4, 2024
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?Mustafa Soytas, Alice Dragomir, Ghady Bou-Nehme Sawaya, et al.Pageof 8